Birth outcomes in women who have taken leflunomide during pregnancy

Arthritis and Rheumatism

Volumn 62, Issue 5, 2010, Pages 1494-1503

  Chambers, Christina D ^a,b   Johnson, Diana L ^a,b   Robinson, Luther K ^c   Braddock, Stephen R ^d   Xu, Ronghui ^a   Lopez Jimenez, Janina ^a,b   Mirrasoul, Nicole ^a,b   Salas, Elizabeth ^a,b   Luo, Yunjun J ^a,b   Jin, Shelia ^a   Jones, Kenneth Lyons ^a,b   Quinn, D ^e   Riordan, S ^e   Kao, K ^a   Brochu, J ^f   LaVigne, S ^f   Conover, E ^g   Roth, M ^h   Miller, R ⁱ   Debus, B ^j   Wolfe, L ^j   Carey, J ^k   Robertson, J ^k   Djokanovic, N ^l   Einarson, A ^l   Koren, G ^l   Briggs, G ^m   Polifka, J ⁿ   Lamm, S ^o   Soldin, O ^p   Berard, A ^q   Gaffaney, C Lyons ^r   Wisner, K ^s   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b RADY CHILDREN'S HOSPITAL   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

^f UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^g UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^h Ferre Institute   (United States)

ⁱ UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^j UNIVERSITY OF NORTH TEXAS   (United States)

^k UTAH DEPARTMENT OF HEALTH   (United States)

^l HOSPITAL FOR SICK CHILDREN   (Canada)

^m LONG BEACH MEMORIAL MEDICAL CENTER   (United States)

ⁿ UNIVERSITY OF WASHINGTON   (United States)

^o Long Beach Memorial Hospital ^*

^p GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^q UNIVERSITÉ DE MONTRÉAL   (Canada)

^r UNIVERSITY OF CALIFORNIA   (United States)

^s UNIVERSITY OF PITTSBURGH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

COLESTYRAMINE; LEFLUNOMIDE;

ADULT; ARTICLE; BIRTH DEFECT; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; HYDRONEPHROSIS; INFANT; LIVE BIRTH; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MICROCEPHALY; MULTICYSTIC DYSPLASTIC KIDNEY; PELVIC DISEASE; PHYSICAL EXAMINATION; POSTNATAL GROWTH; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SPINAL DYSRAPHISM; SPONTANEOUS ABORTION; VESICOURETERAL REFLUX;

EID: 77951756564     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.27358     Document Type: Article

References (20)

1. Brent RL. Teratogen update: reproductive risks of leflunomide (Arava), a pyrimidine synthesis inhibitor; counseling women taking leflunomide before or during pregnancy and men taking leflunomide who are contemplating fathering a child. Teratology 2001;63:106-112
2. Fukushima R, Kanamori S, Hirashiba M, Hishikawa A, Muranaka RI, Kaneto M, et al. Teratogenicity study of the dihydroorotate-dehydrogenase inhibitor and protein tyrosine kinase inhibitor Leflunomide in mice. Reprod Toxicol 2007;24:310-316 (Pubitemid 350016756)
3. Boothby LA, Doering PL. FDA labeling system for drugs in pregnancy. Ann Pharmacother 2001;35:1485-1489
4. Sanofi-Aventis. Arava prescribing information. URL: http://www.sanofi- aventis.us.
5. Chakravarty EF, Sanchez-Yamamoto D, Bush TM. The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: a survey of practice pattern and pregnancy outcomes. J Rheumatol 2003;30:241-246 (Pubitemid 36152584)
6. De Santis M, Straface G, Cavaliere A, Carducci B, Caruso A. Paternal and maternal exposure to leflunomide: pregnancy and neonatal outcome. Ann Rheum Dis 2005;64:1096-1097 (Pubitemid 40909537)
7. Neville CE, McNally J. Maternal exposure to leflunomide associated with blindness and cerebral palsy. Rheumatology (Oxford) 2007;46:1506. (Pubitemid 47317104)
8. Chambers CD, Braddock S, Briggs GG, Einarson A, Johnson YR, Miller RK, et al. Postmarketing surveillance for human teratogenicity: a model approach. Teratology 2001;64:252-261 (Pubitemid 33032707)
9. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-145
10. Marden PM, Smith DW, McDonald MJ. Congenital anomalies in the newborn infant, including minor variations: a study of 4,412 babies by surface examination for anomalies and buccal smear for sex chromatin. J Pediatr 1964;64:357-371
11. Centers for Disease Control and Prevention. Metropolitan Atlanta Congenital Defects Program (MACDP). URL: http://www.cdc.gov/ncbddd/bd/macdp- resources.htm.
12. Leppig KA, Werler MM, Cann CI, Cook CA, Holmes LB. Predictive value of minor anomalies. I. Association with major malformations. J Pediatr 1987;110:531-537
13. Centers for Disease Control and Prevention. National Center for Health Statistics Pediatric Growth Curves, 2000. http://www.cdc.gov/growthcharts.
14. Hall JG, Allanson JE, Gripp KW, Slavotinek AM. Handbook of physical measurements. 2nd ed. Oxford: Oxford University Press; 2007.
15. Jones KL, Lacro RV, Johnson KA, Adams J. Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med 1989;320:1661-1666 (Pubitemid 19154591)
16. Gladstone DJ, Bologa M, Maguire C, Pastuszak A, Koren G. Course of pregnancy and fetal outcome following maternal exposure to carbamazepine and phenytoin: a prospective study. Reprod Toxicol 1992;6:257-261
17. Cambiaghi S, Schiera A, Tasin L, Gelmetti C. Aplasia cutis congenita in surviving co-twins: four unrelated cases. Pediatr Dermatol 2001;18:511-515 (Pubitemid 34111145)
18. Chitayat D, Keating S, Zand DJ, Costa T, Zackai EH, Silverman E, et al. Chondrodysplasia punctata associated with maternal autoimmune diseases: expanding the spectrum from systemic lupus erythematosus (SLE) to mixed connective tissue disease (MCTD) and scleroderma report of eight cases. Am J Med Genet A 2008;146A:3038-3053 (Pubitemid 352774644)
19. Reed SD, Vollan TA, Svec MA. Pregnancy outcomes in women with rheumatoid arthritis in Washington State. Matern Child Health J 2006;10:361-366
20. Henshaw K. Unintended pregnancy in the United States. Fam Plann Perspect 1998;30:24-9, 46.